BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun XJ, Zhang GM, Zhou RJ, Zheng H, Miao N, Yin ZD, Wang FZ. Changes in the epidemiology of hepatitis A in three socio-economic regions of China, 1990-2017. Infect Dis Poverty 2019;8:80. [PMID: 31578150 DOI: 10.1186/s40249-019-0591-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Xiaojin S, Rodewald LE, Guomin Z, Hui Z, Ning M, Fuzhen W, Zundong Y. Long-term seropositivity, safety, and impact of inactivated and live, attenuated hepatitis a vaccines in China – A cross-sectional study. Vaccine 2020;38:8302-9. [DOI: 10.1016/j.vaccine.2020.11.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Hu X, Zhou W, Zhang L, Lv J, Yan B, Zhou Y, Hu W, Dong Y, Chen B, Liu M, Cao J, Xu F, Li L. Implementing sequencing-based surveillance in developing countries: findings from a pilot rollout for hepatitis A in China. Ann Transl Med 2021;9:1119. [PMID: 34430560 DOI: 10.21037/atm-21-1193] [Reference Citation Analysis]
3 Cao G, Jing W, Liu J, Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol Int 2021. [PMID: 34345993 DOI: 10.1007/s12072-021-10232-4] [Reference Citation Analysis]